Application of adenosine-5-triphosphate infusions in palliative home care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN97280223

Enrollment

100

Registered

2006-11-10

Start date

2002-01-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients in the end stage of disease Cancer Cancer

Interventions

Control group: Usual care and additional home visits by a dietician Intervention group: Usual care, additional home visits by a dietician and ATP infus

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cancer patients for whom no systemic treatment is available, or medical treatment options are restricted to palliative/supportive care 2. Life expectancy of less than six months 3. The diagnosis cancer must have been confirmed histologically or cytologically 4. World Health Organisation (WHO) performance status classification in cancer one or two 5. Presence of at least one of the following complaints: a. fatigue b. weight loss over 5% over last six months c. anorexia

Exclusion criteria

Exclusion criteria: 1. Symptomatic angina pectoris 2. Symptomatic heart failure 3. Any form of AtrioVentricular (AV)-block (assessed by Electrocardiogram [ECG]) 4. Cognitive dysfunction or other disease obstructing an adequate follow up 5. Life expectancy of less than four weeks 6. Concurrent palliative chemotherapy

Design outcomes

Primary

Measure	Time frame
1. Quality of life 2. Fatigue 3. Physical restriction	—

Secondary

Measure	Time frame
1. Appetite 2. Nutritional intake 3. Anthropometric measurements 4. Muscle strength 5. Caregiver burden	—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026